Predicting depression treatment response with brain imaging
Part of Mental health clinical trials.
This study uses a special headband (TD-fNIRS) that measures brain activity to see if it can predict how well different depression treatments work. You would be starting a new treatment for depression (like ketamine, SPRAVATO, TMS, or antidepressants) and wear the headband before and during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old (or up to 75 if considering SPRAVATO treatment)
- You have been diagnosed with major depressive disorder (MDD)
- You are planning to start a new depression treatment (ketamine, SPRAVATO, TMS, or antidepressants)
- You haven't had the same treatment in the past 3 to 12 months (depending on the treatment)
- You can speak and read English fluently
- You are not pregnant and can wear a headband that measures brain activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how ketamine given once and then repeatedly may change brain signals and related biomarkers in people with major depression. If you’re eligible, the team will use brain imaging and assessments to see who responds and why.
This study is testing whether brain and heart signals can help predict who will respond to rTMS, a non-invasive treatment that uses magnetic pulses to stimulate parts of the brain. You would receive rTMS for depression and undergo MRI scans and heart monitoring to see if certain patterns predict improvement.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This study uses brain scans and magnetic stimulation to understand depression. It is testing how the brain responds to treatment and may help find better ways to treat depression.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.